Figure 2 CC chemokines including CCL2, CCL3, CCL4, CCL5, CCL7, CCL13, CCL14, CCL16, CCL18, CCL19, CCL20, CCL21, and CCL25 are abnormally expressed in plasma and synovia in RA
Still, the main factor shaping whether employers cover GLP-1 drugs is still cost, Ebert noted, emphasizing plan sponsors generally recognize the clinical value of these medications and their potential to help manage related health conditions, but the expense has been too high for most plans to absorb on a sustained basis
PMID: 102 LiMHuSSunJZhangY
But, as mentioned, this is only one part of the GLP-1 picture
Au HCT, Zheng YJ, Le GH, Wong S, Phan L, Teopiz KM, et al
Key findings include: Tissue Healing: Research shows that BPC-157 peptides promote the repair of muscles, tendons, and ligaments by stimulating new blood vessel growth (angiogenesis)